You are viewing: China Remote Patient Monitoring (RPM) Market analysis

The China Remote Patient Monitoring (RPM) Market was valued at $6789.9 Million in 2026 and projected to reach to $12474 Million by 2031, representing a compound annual growth rate of 12.9%. China's Remote Patient Monitoring market, particularly in cardiac monitoring, is poised for substantial growth as healthcare providers modernize infrastructure to manage chronic disease prevalence.

China Remote Patient Monitoring (RPM) Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Remote Patient Monitoring (RPM) Market Trends and Insights

  • Cardiac Monitoring solutions enable continuous tracking of heart rhythm, arrhythmias, and cardiovascular metrics in real-time, supporting early intervention and reducing hospital readmissions.
  • The segment's growth is driven by rising prevalence of cardiovascular diseases, aging populations, and increasing adoption of wearable cardiac devices that integrate with RPM platforms. Cardiac Monitoring is experiencing accelerated demand as healthcare providers prioritize preventive care and remote management of high-risk cardiac patients.
  • The 12.9% compound annual growth rate reflects strong market momentum through 2031, fueled by technological advances in sensor accuracy, cloud-based data analytics, and regulatory support for remote monitoring reimbursement.
  • Cardiac Monitoring solutions are becoming essential infrastructure for value-based care models, enabling clinicians to monitor patient populations efficiently while reducing operational costs and improving clinical outcomes..

Key Market Statistics

  • CAGR (2026-2031) 12.9% CAGR
  • Market Size, 2026 ~USD 6789.9 Million
  • Forecast, 2031 ~USD 12474 Million
  • Country China

China Remote Patient Monitoring (RPM) Market Overview

Rapid Digital Health Adoption :

China's healthcare system is accelerating RPM integration, driven by government initiatives like the Healthy China 2030 plan and increasing smartphone penetration exceeding 73% of the population, enabling widespread remote monitoring deployment.

Aging Population Pressure :

With 280+ million citizens aged 60+, China faces unprecedented cardiovascular disease burden. RPM solutions address critical gaps in rural healthcare access, where 40% of the population lacks adequate cardiac monitoring infrastructure.

Government Policy Support :

The National Health Commission's push for telemedicine reimbursement and integration into medical insurance schemes has created favorable regulatory conditions for RPM market expansion across urban and rural regions.

Technology Infrastructure Growth :

5G rollout across 300+ cities and cloud computing investments position China as a leader in real-time cardiac data transmission, enabling seamless integration of wearables with hospital information systems.

China Remote Patient Monitoring (RPM) Market Dynamics

  • The 12.9% CAGR reflects strong demand from both urban hospitals seeking operational efficiency and rural clinics addressing specialist shortages.
  • Government reimbursement policies and mandatory health insurance coverage expansions are accelerating adoption among middle-income populations.
  • By 2031, the market is expected to reach $12,474 million, driven by integration of AI-powered diagnostics and wearable technology.
  • Domestic manufacturers are gaining competitive advantage through cost-effective solutions tailored to China's healthcare ecosystem, while international players establish partnerships with local providers to capture market share..

Related Ecosystem

Cardiovascular Devices

Top Technologies
  • External Defibrillators
  • Implantable Cardioverter Defibrillators
  • Pulse Oximeters
  • Robotic Systems
  • 3-Lead ECG Leadwires
Top Companies
  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Terumo Corporation
  • KONINKLIJKE PHILIPS N.V.

    Diagnostic Imaging

    Top Technologies
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT)
    • CT Scanners
    • Nuclear Imaging
    • Positron Emission Tomography
    Top Companies
    • Siemens healthineers
    • PHILIPS HEALTHCARE
    • CANON INC.
    • FUJIFILM Holdings Corporation
    • UNITED IMAGING HEALTHCARE CO., LTD.

      Healthcare It

      Top Technologies
      • Computed Tomography (CT)
      • Machine Learning
      • Magnetic Resonance Imaging (MRI)
      • Natural Language Processing (NLP)
      • Predictive Analytics
      Top Companies
      • CERNER CORPORATION
      • PHILIPS HEALTHCARE
      • Oracle Corporation
      • GE HealthCare Technologies Inc.
      • Siemens healthineers

        Key Takeaways

        • Cardiac Monitoring market valued at $6,789.9M in 2026, expanding to $12,474.0M by 2031 at 12.9% CAGR
        • Cardiac Monitoring enables real-time tracking of arrhythmias and cardiovascular metrics, reducing hospital readmissions and supporting early intervention
        • Cardiac Monitoring adoption accelerated by wearable device integration, cloud analytics, and reimbursement policy support
        • Cardiac Monitoring is foundational to value-based care models, improving clinical outcomes while reducing operational costs

        Remote Patient Monitoring (RPM) Market Report Scope

        Report Metric Details
        Base Year 2026
        Fastest Growing Segment ASIA PACIFIC (Indication)
        Forecast Period 2026–2031
        Growth Rate CAGR of 12.8% from 2026 to 2031
        Largest Segment DEVICES (Component)
        Market Size Base Year (Billions) ~USD 36.32 (2026)
        Revenue Forecast (Billions) ~USD 66.33 (2031)
        Segments Covered Component, Function, Type, Deployment Model, Transmission Type, Indication, End User, Deployment Type

        China Remote Patient Monitoring (RPM) Market Report Segmentation

        8 segment dimensions are covered across the global market.

        By Component

        • Devices
        • Services
        • Software

        By Function

        • Blood Glucose Monitoring
        • Blood Glucose Monitoring Devices
        • Cardiac Monitoring
        • Cardiac Monitoring Devices
        • Fetal & Neonatal Monitoring
        • Fetal & Neonatal Monitoring Devices
        • Multiparameter Monitoring
        • Multiparameter Monitoring Devices
        • Neurological Monitoring
        • Neurological Monitoring Devices
        • Other Monitoring Devices
        • Pulse Oximeter Devices
        • Pulse Oximeters
        • Respiratory Monitoring
        • Respiratory Monitoring Devices
        • Thermometers
        • Weight Monitoring
        • Weight Monitoring Devices

        By Type

        • Ambulatory Surgical Centers, Ambulatory Care Centers, And Other Outpatient Settings
        • Ascs, Accs, And Other Outpatient Settings
        • Handheld & Portable Devices
        • Home Healthcare
        • Hospitals
        • Implantable Devices
        • Long-Term Care & Assisted Living Facilities
        • Other Devices
        • Other Healthcare Providers
        • Wearable Devices

        By Deployment Model

        • Cloud-Based Models
        • On-Premise Models

        By Transmission Type

        • Asynchronous
        • Synchronous

        By Indication

        • Cardiology
        • Diabetes
        • Mental Health
        • Neurology
        • Oncology
        • Other Indications
        • Respiratory Disorders
        • Sleep Disorders
        • Wellness Improvement

        By End User

        • Healthcare Payers
        • Healthcare Providers
        • Medtech Companies
        • Other End Users
        • Patients
        • Pharmaceutical & Biotechnology Companies

        By Deployment Type

        • Cloud-Based Models
        • On-Premise Models

        Target Audience

        • Healthcare Providers & Hospital Networks : Hospital administrators and cardiac departments need market data to justify RPM investments, optimize patient management workflows, and align procurement strategies with government reimbursement policies.
        • Medical Device Manufacturers : Device companies require competitive analysis, market sizing, and regulatory insights to develop China-compliant cardiac monitoring solutions and establish distribution partnerships with local healthcare systems.
        • Digital Health & Telemedicine Startups : Emerging health tech companies need market validation, growth forecasts, and customer segmentation data to secure funding, prioritize product development, and plan market entry strategies in China.
        • Insurance & Healthcare Payers : Insurance companies and government health agencies require market intelligence to design reimbursement models, assess cost-effectiveness of RPM solutions, and plan coverage expansion initiatives.
        • Investment & Strategy Consultants : Private equity firms, venture capitalists, and management consultants need comprehensive market analysis to identify acquisition targets, evaluate portfolio companies, and guide strategic expansion in China's healthcare sector.

        Key Companies in the China Remote Patient Monitoring (RPM) Market

        CompanyHQOwnershipStrongest segments
        KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnosis & Treatment (Imaging and Image Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep and Respiratory Care),Personal Health,
        MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes and Monitoring),
        GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS),
        ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
        ORACLEUnited StatesPublic CompanyCloud Applications (Fusion ERP/EPM/SCM/HCM, NetSuite, CX, Health),Database and Infrastructure Technologies (Oracle DB, MySQL, Autonomous, Middleware, Java),Cloud Infrastructure (Compute, Storage, Networking, AI/ML, Digital Assistant, Blockchain),
        BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, LAAC, peripheral interventions),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
        NIHON KOHDEN CORPORATIONJapanPublic CompanyPatient monitors and clinical information systems,Physiological measuring equipment (EEG, ECG, EMG, polygraphs),Defibrillators, AEDs, and resuscitation devices,
        SIEMENS HEALTHINEERS AGGermanyPublic CompanyImaging,Diagnostics,Varian (Oncology),
        BAXTERUnited StatesPublic CompanyMedical Products & Therapies (IV solutions, infusion, parenteral nutrition, renal and related therapies),Healthcare Systems & Technologies (smart beds, monitoring, OR integration, surgical equipment, respiratory devices),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services),

        KONINKLIJKE PHILIPS N.V.

        Koninklijke Philips N.V. is a Dutch multinational public company founded in 1891 with 64,317 employees, operating across healthcare and technology sectors.

        MEDTRONIC

        Medtronic is a public medical technology company founded in 1949 in Ireland with 95,000 employees, providing medical devices and healthcare solutions.

        GE HEALTHCARE

        GE Healthcare is a public healthcare company established in 2022 in the United States with 54,000 employees, offering medical imaging and healthcare technology.

        ABBOTT

        Abbott is a public healthcare and diagnostics company founded in 1888 in the United States with 115,000 employees.

        ORACLE

        Oracle is a public software and cloud computing company founded in 1977 in the United States with 141,000 employees.

        BOSTON SCIENTIFIC CORPORATION

        Boston Scientific Corporation is a public medical device company founded in 1979 in the United States with 59,000 employees.

        NIHON KOHDEN CORPORATION

        Nihon Kohden Corporation is a Japanese public company founded in 1951 with 6,116 employees, specializing in medical equipment and healthcare technology.

        SIEMENS HEALTHINEERS AG

        Siemens Healthineers AG is a German public healthcare company founded in 1896 with 72,369 employees, providing medical imaging and diagnostic solutions.

        BAXTER

        Baxter is a public healthcare company founded in 1931 in the United States with 37,500 employees, specializing in medical devices and pharmaceuticals.

        Reasons to Buy this Report

        • Market Size & Growth Validation : Obtain precise valuation data for China's RPM segment ($6,789.9M in 2026, growing to $12,474M by 2031) to benchmark investments and identify revenue opportunities in Asia's largest healthcare market.
        • Regulatory & Reimbursement Landscape : Understand China-specific government policies, insurance coverage mechanisms, and compliance requirements essential for market entry, partnership development, and product localization strategies.
        • Competitive Intelligence : Analyze domestic and international competitor positioning, identify market gaps, and assess the competitive advantages of local manufacturers versus foreign entrants in China's RPM ecosystem.
        • Demographic & Clinical Insights : Leverage data on China's aging population, cardiovascular disease prevalence, and rural-urban healthcare disparities to target high-potential customer segments and design region-specific solutions.
        • Technology & Infrastructure Trends : Evaluate 5G deployment, cloud infrastructure maturity, and wearable device adoption rates across China to assess technical feasibility and scalability of RPM implementations.

        Frequently asked questions

        What is the market size of Cardiac Monitoring in 2026?

        Cardiac Monitoring is valued at $6,789.9 million in 2026, representing a significant segment within the broader Remote Patient Monitoring market.

        What is the projected market size for Cardiac Monitoring by 2031?

        Cardiac Monitoring is forecast to reach $12,474.0 million by 2031, reflecting strong growth momentum across the forecast period.

        What is the CAGR for Cardiac Monitoring from 2026 to 2031?

        Cardiac Monitoring is expected to grow at a compound annual growth rate of 12.9% between 2026 and 2031.

        What drives growth in the Cardiac Monitoring segment?

        Cardiac Monitoring growth is driven by rising cardiovascular disease prevalence, aging populations, wearable device adoption, cloud-based analytics, and expanded reimbursement policies for remote monitoring.

        How does Cardiac Monitoring improve patient outcomes?

        Cardiac Monitoring enables continuous real-time tracking of heart rhythm and arrhythmias, supporting early intervention, reducing hospital readmissions, and enabling proactive clinical management of high-risk patients.

        RESEARCH METHODOLOGY

        The study involved major activities in estimating the current market size for the remote patient monitoring market.

        Exhaustive secondary research was done to collect information on the remote patient monitoring industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the remote patient monitoring market.  

        Secondary Research

        In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of the remote patient monitoring market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

        Primary Research

        Extensive primary research was conducted after acquiring basic knowledge about the global remote patient monitoring market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

        BREAKDOWN OF PRIMARY INTERVIEW PARTICIPANTS

        Remote Patient Monitoring Market 
 Size, and Share

        Note 1: Others include sales managers, marketing managers, and product managers.

        Note 2: Tiers of companies are defined on the basis of their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

        To know about the assumptions considered for the study, download the pdf brochure

        Market Size Estimation

        Both top-down and bottom-up approaches were used to estimate and validate the total size of the remote patient monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market.

         The research methodology used to estimate the market size includes the following:

        Remote Patient Monitoring Market Top Down and Bottom Up Approach

        Data Triangulation

        After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the remote patient monitoring market.

        Market Definition

        The remote patient monitoring (RPM) market involves the use of technology to remotely monitor and manage patients' health conditions outside of traditional healthcare settings, as well as in patient settings. It leverages devices such as wearables, sensors, and mobile applications to track vital signs and chronic diseases. RPM allows healthcare providers to access real-time data for better decision-making and personalized care.

        Key Stakeholders

        • RPM Equipment and devices Manufacturers
        • Suppliers and Distributors of RPM Equipment
        • RPM software provider
        • Healthcare IT Service Providers
        • Healthcare Insurance Companies/Payers
        • Healthcare Institutions/Providers (Hospitals, Clinics, Medical Groups, Physician Practices, Diagnostic Centers, and Outpatient Clinics)
        • Venture Capitalists
        • Government Bodies/Regulatory Bodies
        • Corporate Entities
        • Accountable Care Organizations
        • RPM Resource Centers
        • Research and Consulting Firms
        • Medical Research Institutes
        • Clinical Departments

        Report Objectives

        • To define, describe, and forecast the global remote patient monitoring market based on component, indication, end user, and region.
        • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
        • To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall remote patient monitoring market
        • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
        • To strategically analyze the market structure profile of the key players of the remote patient monitoring market and comprehensively analyze their core competencies.
        • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
        • To track and analyze competitive developments such as product launches and enhancements, investments, partnerships, collaborations, acquisitions, expansions, funding, grants, agreements, sales contracts, product testing, FDA approval, product approval, and alliances in the remote patient monitoring market during the forecast period.

        Available customizations:

        With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

        • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
        • Geographic Analysis:  Further breakdown of Latin American remote patient monitoring into specific countries, the Middle East, and Africa remote patient monitoring into specific countries, and further breakdown of European remote patient monitoring into specific countries

         

        Get the Full Remote Patient Monitoring (RPM) Market Report

        Full forecast, segment splits, and company analysis for all Remote Patient Monitoring (RPM) Market.

        Need a Tailored Report?

        Customize this report to your needs

        Get 10% FREE Customization

        Customize This Report
        Fact checked
        DMCA.com Protection Status